SR One

SR One

Redwood City, Californiasrone.com

Overview

SR One is a transatlantic biotechnology venture capital firm that partners with entrepreneurs and investment partners to build elite biotechnology companies. The firm focuses on translating innovative technologies and scientific discoveries into next-generation medicines with the potential to benefit patients with significant unmet medical needs. SR One takes a back-and-build approach to its investments, focusing on companies with strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases.

Year Founded

1985

AUM

$1.5B

Portfolio Companies

63

Website

srone.com

Investments

CompanyDateStageLead
ImmuneBiotechMay 2026Growth EquityCo-investor
Windward BioMay 2026Growth EquityCo-investor
ImmutrinMar 2026Series ACo-investor
AirNexis TherapeuticsMar 2026Series ACo-investor
Poplar TherapeuticsMar 2026Series A ExtensionCo-investor

Key People

Simeon George

Chief Executive Officer And Co-Founder

Rajeev Dadoo

Managing Partner

Christopher Chai

Venture Partner

Jake Bauer

Venture Partner

Matthew Patterson

Venture Partner

peter van vlasselaer

Venture Partner

Jake Nunn

Partner

Jill Carroll

Partner

Michael Diem

Partner

Amit Shah

Principal

Mahesh Kudari

Biotech Venture Capital

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersRedwood City, California
Year Founded1985
AUM$1.5B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.